Santé Ventures Lures Toronto's Molecular Templates to Texas with $2.5M Financing Round | GenomeWeb

Molecular Templates, a cancer therapeutics shop based on technology developed at the Ontario Cancer Institute and University of Toronto, will relocate from Toronto to Texas after closing a $2.5 million Series A venture financing round from Austin-based Santé Ventures, the venture capital firm said last week.

Molecular Templates will use the financing to advance into clinical trials a lead melanoma compound, and to develop other cancer therapeutics using its proprietary protein-engineering and high-throughput screening platform technology.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.